From the perspective of product cultivation, we formulate R&D strategic blueprints for TCM products. Services include: market demand exploration, competitive product analysis, clinical value mining of products, and full-lifecycle R&D planning. The specific implementation approach adopts the methodology of "market demand exploration, competitive product analysis, and product value mining based on literature, survey, and sales data; top-level expert review and validation, clinical study protocol design, and integrated resource allocation for phased implementation," integrating clinical trials with product cultivation to provide a scientific pathway for products to transition from "outstanding varieties" to "major varieties."
Centered on the core clinical value of the product, we progressively advance retrospective studies, cohort observations, prospective RCTs, large-sample multi-center RCTs, and real-world evidence studies, forming a "pyramid"-shaped evidence system from lower to higher levels, and driving the product into clinical guidelines, expert consensus, and clinical pathways.
New indication expansion is the core pathway for major varieties to break through growth ceilings, as opening up a new indication unlocks a new market. Our company provides full-process support from indication screening and evaluation, clinical trial protocol design, clinical trial organization and implementation, to regulatory submission, all built upon the foundation of the evidence-based evidence system established in the earlier stages.
AAcademic promotion and brand building serve as the engine for transforming major varieties from "having evidence" to "being used." The core philosophy is to drive prescribing habits through academic consensus, establish systematic academic propositions around the product's clinical positioning, form a national-level academic committee, continuously publish high-quality papers to build a literature matrix, and promote the development of expert consensus and clinical application guidelines to embed the product into diagnostic and treatment standards.
Breaking through the limitations of traditional single-service offerings, we provide integrated system solutions covering the entire process from "top-level design – clinical research – new indication expansion – brand building – market promotion." From clinical evidence generation and registration access strategy formulation to marketing execution and product life-cycle redevelopment, we form a complete closed loop from value discovery to value realization.
Bringing together expert resources from multiple fields including TCM pharmacology, clinical medicine, pharmacy, evidence-based medicine, and marketing, we have built a multidisciplinary talent team that synergizes "industry-academia-research-medicine-application." We are able to concurrently coordinate medical research and market planning, break down professional barriers, and effectively address the common challenge in major TCM variety cultivation of "disconnection between science and the market."
Leveraging digital tools such as clinical research big data platforms, we precisely identify product clinical advantages and market demands, reduce R&D risks, and enhance decision-making efficiency.
With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.
